Featured Research

from universities, journals, and other organizations

UK Researchers Raise Hopes Of Preserving Fertility For Women With Cancer

Date:
September 27, 2001
Source:
European Society For Human Reproduction And Embryology
Summary:
UK fertility experts have sounded a note of cautious optimism about the safety of preserving ovarian tissue and transplanting it back into women after cancer treatment.

UK fertility experts have sounded a note of cautious optimism about the safety of preserving ovarian tissue and transplanting it back into women after cancer treatment.

Related Articles


The optimism follows research reported in Human Reproduction*, Europe’s leading journal of reproductive medicine. It is the first reported non-test tube investigation in the world on the safety of grafting ovarian tissue from cancer patients.

Women are often rendered infertile after drug or radiation treatment for cancer and scientists have for a long time been looking at ways to make it possible for women to have babies after they have recovered from treatment.

For those who have no partner, young girls, or women who require immediate treatment, embryo freezing is not feasible.

But another option - preserving ovarian tissue before treatment and transplanting it into the patient after treatment to reinstate fertility - in addition to being technically difficult, raises concerns that cancer cells lurking within the tissue could be re-introduced into the body with disastrous results.

Now a study in mice by teams from Leeds and Manchester** led by Dr S. Samuel Kim has shown that fears about reintroducing cancer may be over-stated (at least in lymphoma patients) and that preserving ovarian tissue for later autotransplanation might be the viable option for young cancer patients anxious to preserve their fertility.

The researchers grafted frozen and thawed ovarian tissue from 18 women with non-Hodgkins Lymphoma or Hodgkins Lymphomas (cancers of the lymph glands) into 30 immunodeficient mice. For controls, they grafted a disease-positive lymph node from a patient with a recurrent B-cell lymphoma, into three immunodeficient mice. None of the mice grafted with the ovarian tissue developed human lymphomas, but all three of the mice who received a graft from a diseased lymph node developed human B-cell lymphomas.

Dr Kim said: "Ovarian tissue from cancer patients has been banked at many centres worldwide in preparation ultimately for transplantation back into patients after successful treatment. However, this step requires prior assurance that the tissue will not transmit disease after grafting.

"This is the first reported in-vivo investigation of residual malignant disease in human ovarian tissue using a xenograft and this model, involving immunodeficient mice, may help to confirm clinical decisions about the risks of transplanting ovarian tissue back into cancer patients.

"Our patients were deliberately selected for having high-risk disease and in the three years following tissue harvesting, half have died of lymphoma. So the study was based on worst-case scenarios of highly aggressive lymphomas that were likely to have already spread at the time the ovarian tissue was harvested."

He said the immunodeficient mouse model was suitable for investigating the safety of ovarian transplantation, serving as a practical screen for the disease. While the study had focused on lymphoma, it was also an appropriate model for other cancers.

However, he warned that the follow-up period was relatively short because of the naturally short life span of the mice and that efforts to develop new techniques to detect residual disease should continue.

"Nevertheless, our findings are of immediate relevance to women with lymphomas who are considering banking ovarian tissue for fertility conservation and also to their physicians who need to provide them with appropriate advice. We can now be more optimistic about the application of ovarian cryopreservation and transplantation in cancer patients, although these reassuring findings should not be interpreted as an absolute indication of safety."

Dr Kim said the research teams were now working on finding a method to screen cancer cells in ovarian tissue from patients before transplantation, and on laboratory and animal techniques to grow and mature primordial ovarian follicles.

Notes:

* Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Human Reproduction. Vol 16. No 10. pp 2056-2060.

** The research teams involved: Centre for Reproduction, Growth and Development, University of Leeds; Department of Medical Oncology and Department of Histopathology, Christie Hospital, NHS Trust, Manchester; Department of Cancer Genetics, Paterson Institute for Cancer Research, Manchester; Department of Reproductive Medicine, St Mary’s Hospital, Manchester; Department of Endocrinology, Christie Hospital NHS Trust, Manchester.

Researchers were: S. Samuel Kim (currently in USA), John Radford, Martin Harris, Jenny Varley, Anthony J Rutherford, Brian Leiberman, Steven Shalet and Roger Gosden (currently in Canada).


Story Source:

The above story is based on materials provided by European Society For Human Reproduction And Embryology. Note: Materials may be edited for content and length.


Cite This Page:

European Society For Human Reproduction And Embryology. "UK Researchers Raise Hopes Of Preserving Fertility For Women With Cancer." ScienceDaily. ScienceDaily, 27 September 2001. <www.sciencedaily.com/releases/2001/09/010927072309.htm>.
European Society For Human Reproduction And Embryology. (2001, September 27). UK Researchers Raise Hopes Of Preserving Fertility For Women With Cancer. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2001/09/010927072309.htm
European Society For Human Reproduction And Embryology. "UK Researchers Raise Hopes Of Preserving Fertility For Women With Cancer." ScienceDaily. www.sciencedaily.com/releases/2001/09/010927072309.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins